LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ)
$3.77 0.125 (3.4294%)
Analysed LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) News Sources
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
30-10-2025
yahoo.com
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
17-02-2026
yahoo.com
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
17-03-2026
yahoo.com
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pipeline
30-06-2026
yahoo.com
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement
13-08-2026
yahoo.com
Liminatus Pharma Announces Nasdaq Delisting Notification
22-05-2026
yahoo.com
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
03-06-2026
yahoo.com
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock
18-08-2026
yahoo.com
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
24-08-2026
yahoo.com
What is the current price of LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ)?
The current price of LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) is $3.77.
LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) since the previous trading day is $0.125.
LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) since the previous trading day is 3.4294%.
What is the most recent average sentiment score for LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ)?
The most recent average sentiment score for LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ)?
The most recent sentiment for LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ) is .
SEC-8K** Filing Available For LIMINATUS PHARMA INC-CL A (LIMN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.